 WILMINGTON, Del., Dec. 14, 2020 GLOBE NEWSWIRE -- Rigrodsky Long, P.A. announces that it is investigating Alexion Pharmaceuticals, Inc. Alexion NASDAQ GS: ALXN regarding possible breaches of fiduciary duties and other violations of law related to Alexions agreement to be acquired by AstraZeneca PLC AstraZeneca NASDAQ GS: AZN. Under the terms of the agreement, Alexions shareholders will receive 2.1243 American Depository Shares of AstraZeneca and 60.00 in cash per share. 